Lv1
58 积分 2025-04-18 加入
Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
24天前
已关闭
Phase I trial of a heat-conditioned tumor lysate vaccine (TRIMELVax) in anti-PD-1 refractory melanoma: safety and immunological aspects (NCT06556004)
1个月前
已关闭
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma
1个月前
已完结
SHR-A2102, a nectin-4 directed antibody–drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial
1个月前
已完结
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial
1个月前
已完结
Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial
2个月前
已完结
Intracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial
2个月前
已完结
DNA, Peptide Vaccines Advance Against GBM
2个月前
已关闭
Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial
2个月前
已完结
Localized PD-1 CAR T therapy reprograms neuroinflammation
2个月前
已完结
皖公网安备34019202002308
